Britt Meelby Jensen steps down as CEO of Atos Medical

On the day that Coloplast announces the completion of the acquisition of Atos Medical, Britt Meelby Jensen announces her departure as the Swedish company’s CEO. Seasoned Coloplast leader steps in to fill the position.

Britt Meelby Jensen is stepping down as CEO of Atos Medical | Photo: Atos Medical

After three years at the front of Swedish medtech company Atos Medical, Britt Meelby Jensen has set the date for when she will leave the company, a press release announces.

On March 1, 2022, the former Zealand Pharma CEO steps back from the position in Atos Medical, which Coloplast acquired for EUR 2.2bn in November. The news of Meelby Jensen’s exit is announced on the same day that Coloplast announces that the acquisition has been formally completed, and Atos Medical is now officially a part of the Coloplast group.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs